Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.aspiradiagnostics.com | |
Market Cap | 31.91 Cr. | |
Enterprise Value(EV) | 29.04 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.57 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 19.77 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 49.39 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 12.59 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.46 | Calculated using Price: 31.00 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.03 Cr. | 10,293,000 Shares |
FaceValue | 10 | |
About Aspira Pathlab & Diagnostics Ltd. | ||
The Company is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. |
1 Day |
|
-4.32% |
1 Week |
|
-3.12% |
1 Month |
|
-5.17% |
3 Month |
|
-13.41% |
6 Month |
|
-27.65% |
1 Year |
|
-42.06% |
2 Year |
|
+3.68% |
5 Year |
|
+73.96% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.55 | 1.10 | 0.76 | -57.04 | -178.61 | -187.57 | -94.32 | 22.80 | 42.26 | |
Return on Capital Employed (%) | 3.88 | 3.95 | 1.78 | -25.35 | -38.38 | -34.50 | -26.30 | 21.52 | 41.63 | |
Return on Assets (%) | 2.55 | 1.05 | 0.54 | -25.76 | -40.76 | -37.93 | -29.11 | 10.58 | 29.82 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 1 | 4 | 4 | 6 | 0 | 5 | 4 | 8 | 13 | 13 | |
Non Curr. Liab. | 3 | 11 | 5 | 5 | 1 | 4 | 3 | ||||
Curr. Liab. | 0 | 3 | 6 | 2 | 4 | 5 | 2 | 2 | 2 | ||
Minority Int. | |||||||||||
Equity & Liab. | 1 | 4 | 6 | 15 | 13 | 15 | 14 | 12 | 18 | 18 | |
Non Curr. Assets | 1 | 11 | 11 | 13 | 11 | 8 | 11 | 10 | |||
Curr. Assets | 1 | 4 | 6 | 4 | 2 | 2 | 3 | 4 | 7 | 7 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1 | 4 | 6 | 15 | 13 | 15 | 14 | 12 | 18 | 18 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 1 | 4 | 8 | 8 | 15 | 20 | 16 | ||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 0 | 0 | 0 | 1 | 5 | 8 | 9 | 15 | 20 | 17 | |
Total Expenditure | 0 | 0 | 0 | -3 | -8 | -11 | -10 | -12 | -13 | -13 | |
PBIDT | 0 | 0 | 0 | -2 | -4 | -3 | -2 | 4 | 6 | 4 | |
Interest | 0 | 0 | 0 | -1 | -1 | -1 | -1 | 0 | 0 | ||
Depreciation | 0 | -1 | -1 | -2 | -1 | -2 | -2 | ||||
Taxation | 0 | 0 | 0 | 0 | |||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | -3 | -6 | -5 | -4 | 1 | 4 | 2 | |
Adjusted EPS | 0 | 0 | 0 | -5 | -11 | -6 | -5 | 1 | 4 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | -5 | -3 | -2 | 6 | 2 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 0 | -10 | -1 | -2 | 0 | 0 | -1 | |
Cash Fr. Finan. | 3 | 3 | 9 | 7 | 3 | 1 | -2 | -1 | |||
Net Change | 0 | 0 | 3 | 2 | -3 | 1 | -2 | 0 | 3 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 3 | 5 | 3 | 0 | -2 | -2 | 1 | 1 |
Sat, 27 May 2023
Announcement Under Regulation 30 (LODR)-Appointment Of Secretarial Auditor And Internal Auditor Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held on Saturday May 27 2023 has approved the appointment of M/s. Nilesh A. Pradhan & Co. LLP Practicing Company Secretary as a Secretarial Auditor and M/s. Vishal Bhanushali & Associates Chartered Accountant as an Internal Auditor of the Company. The Information required to be submitted pursuant to Regulation 30 of the Listing Regulations is marked and attached as Annexure-A & B. |
Sat, 27 May 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 27 May 2023 Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) the Board of Directors of the Company at their held on Saturday 27th May 2023 which was commenced at 03:30 P.M. and concluded at 05:20 PM. Attached Agenda items were approved in the meeting. |
Sat, 27 May 2023
Financial Result For The Period Ended 31St March 2023 Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) this is to inform that Board of Directors of the Company in their meeting held today i.e. May 27 2023 has inter-alia considered and approved the Audited Financial Results for the year ended on March 31 2023.Please find attached:Audited Financial Results for the year ended on March 31 2023 along with statement of Assets & Liabilities and Cash Flow Statement Auditors Report and Declaration about unmodified opinion in audit report. |
Fri, 26 May 2023 |
|
|
|
|
|